-J Ware Researcher Activity Profile

Research Author Detailed Information 

J Ware Publication Rate By Year

J Ware has published 1 paper(s) in 1983, 1 paper(s) in 1986, 1 paper(s) in 1989, 1 paper(s) in 1990, 2 paper(s) in 1991, 1 paper(s) in 1992, 8 paper(s) in 1993, 1 paper(s) in 1995, 3 paper(s) in 1996, 3 paper(s) in 1997, 4 paper(s) in 1998, 1 paper(s) in 1999, 2 paper(s) in 2000, 4 paper(s) in 2006, 4 paper(s) in 2007, for a total of 37 research publications in total.

J J Ware Author Information

LAST NAME: ware

FIRST NAME: j

INITIALS: J

AFFILIATION:

Papers

J Ware's Publication Record

1. Platelet septin complexes form rings and associate with the microtubular network. Year Published: 2006
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72223, USA.
2. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. Year Published: 2006
Department of Molecular and Experimental Medicine, Division of Experimental Hemostasis and Thrombosis, The Roon Center for Arteriosclerosis and Thrombosis, The Scripps Research Institute, La Jolla, CA, USA.
3. FcRgamma-chain signals in the absence of glycoprotein VI. Year Published: 2007
4. FcRgamma-chain-dependent alphaIIbeta3 elicited outside-in signaling. Year Published: 2007
5. Fluid homeostasis in haemorrhage. Experimental studies in the rat. Year Published: 1983
6. Clinical evaluation of the neurophysins as tumor markers in small cell lung cancer. Year Published: 1986
7. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Year Published: 2000
Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. jware@scripps.edu
8. Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins. Year Published: 2000
Center for Blood Research and the Department of Pathology, Harvard Medical School, Boston, MA, USA.
9. Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties. Year Published: 1989
Department of Biology, University of North Carolina, Chapel Hill 27599-3280.
10. Nonsense mutation in the glycoprotein Ib alpha coding sequence associated with Bernard-Soulier syndrome. Year Published: 1990
Roon Research Center for Cardiovascular Disease and Thrombosis, Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, La Jolla, CA 92037.
11. Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor. Year Published: 1991
Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Research Institute of Scripps Clinic, La Jolla, CA 92037.
12. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. Year Published: 1991
Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation, La Jolla, California 92037.
13. The structure and function of von Willebrand factor. Year Published: 1992
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
14. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide. Year Published: 1993
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
15. Disulfide bond requirements for assembly of the platelet glycoprotein Ib-binding domain of von Willebrand factor. Year Published: 1993
Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
16. von Willebrand factor. Year Published: 1993
Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
17. A role for von Willebrand factor proline residues 702-704 in ristocetin-mediated binding to platelet glycoprotein Ib. Year Published: 1993
Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037.
18. Expression of human platelet glycoprotein Ib alpha in transgenic mice. Year Published: 1993
Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
19. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment. Year Published: 1993
Department of Molecular and Experimental Medicine/Committee on Vascular Biology, Roon Research Center for Arteriosclerosis and Thrombosis, Scripps Research Institute, La Jolla, California 92037.
20. von Willebrand factor mutation enhancing interaction with platelets in patients with normal multimeric structure. Year Published: 1993
Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
21. Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome. Year Published: 1993
Roon Research Laboratory for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037.
22. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. Year Published: 1995
Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular Medicine, Scripps Research Institute, La Jolla, California 92037, USA.
23. Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease. Year Published: 1996
Universitäts-Kinderklinik, Kiel, Germany.
24. Conformational changes in the A1 domain of von Willebrand factor modulating the interaction with platelet glycoprotein Ibalpha. Year Published: 1996
Roon Research Center for Arteriosclerosis and Thrombosis, Scripps Research Institute, La Jolla, California 92037.
25. Isolated recombinant domain of von Willebrand factor displaying increased sensitivity to ristocetin. Year Published: 1996
Department of Clinical Laboratory Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan.
26. Controlling elements of platelet glycoprotein Ib alpha expression. Year Published: 1997
Roon Center for Arterioscerosis and Thrombosis, Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
27. Crystal structure of NMC-4 fab anti-von Willebrand factor A1 domain. Year Published: 1997
Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
28. A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype. Year Published: 1998
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital and University of Milano, Italy.
29. Cloning of the murine platelet glycoprotein Ibalpha gene highlighting species-specific platelet adhesion. Year Published: 1997
Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. jware@scripps.edu
30. Crystal structure of the von Willebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Year Published: 1998
Roon Research Center for Arteriosclerosis and Thrombosis, The Scripps Research Institute, La Jolla, California 92037, USA.
31. Cloning and deduced amino acid sequence of human nicotinamide nucleotide transhydrogenase. Year Published: 1998
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
32. Molecular analyses of the platelet glycoprotein Ib-IX-V receptor. Year Published: 1998
Roon Research Center for Arteriosclerosis and Thrombosis, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA. jware@scripps.edu
33. Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field. Year Published: 1999
Roon Research Center for Arteriosclerosis and Thrombosis, Division of Experimental Hemostasis and Thrombosis, Departments of Molecular and Experimental Medicine, and Vascular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
34. Platelet septin complexes form rings and associate with the microtubular network. Year Published: 2006
Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR 72223, USA.
35. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. Year Published: 2006
Department of Molecular and Experimental Medicine, Division of Experimental Hemostasis and Thrombosis, The Roon Center for Arteriosclerosis and Thrombosis, The Scripps Research Institute, La Jolla, CA, USA.
36. FcRgamma-chain signals in the absence of glycoprotein VI. Year Published: 2007
37. FcRgamma-chain-dependent alphaIIbeta3 elicited outside-in signaling. Year Published: 2007